BioNexus Gene Lab Corporation Share Price Other OTC
Equities
BGLC
US0906281086
Biotechnology & Medical Research
Sales 2022 | 10.93M 871M | Sales 2023 | 9.77M 779M | Capitalization | 9.36M 746M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -2M -159M | EV / Sales 2022 | 14.9 x |
Net cash position 2022 | 2.06M 164M | Net cash position 2023 | 5.78M 461M | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
-461
x | P/E ratio 2023 |
-3.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.63% |
Managers | Title | Age | Since |
---|---|---|---|
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 31/07/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Keong Yap
BRD | Director/Board Member | 68 | 06/03/22 |
Wei Foong Lim
BRD | Director/Board Member | 48 | 12-10 |
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 31/07/23 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |